168
Participants
Start Date
March 12, 2021
Primary Completion Date
December 30, 2021
Study Completion Date
February 28, 2022
No intervention.
Observational study with no intervention.
Mount Sinai Hospital, New York
University of Pittsburgh, Pittsburgh
University of North Carolina Chapel Hill, Chapel Hill
University of California San Fransisco Medical Center, San Francisco
Oregon Health and Science University, Portland
Hackensack Meridian Health, Nutley
Lead Sponsor
Weill Medical College of Cornell University
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Duke University
OTHER